XLON
ELIX
Market cap338mUSD
Oct 09, Last price
516.00GBP
1D
0.00%
1Q
-23.44%
IPO
152.32%
Name
Elixirr International PLC
Chart & performance
P/E
12.98
P/S
1.71
EPS
0.40
Div yield, %
3.45%
Shrs. gr., 5y
3.49%
Rev. gr., 5y
37.61%
Revenues
150m
+34.36%
Net income
20m
+20.25%
CFO
32m
+7.32%
Dividend
Jul 23, 202615 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Elixirr International plc, along with its various subsidiaries, delivers expert management consulting services across the United Kingdom, the United States, and other international territories. The company's core offerings encompass creative strategies, marketing initiatives, and self-financed transformation programs. Its extensive client base covers a wide range of industries, such as automotive and transportation, manufacturing, business and financial services, non-profit organizations, energy, utilities and natural resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and hospitality, telecommunications, technology, retail and consumer goods, private equity, media, and the entertainment and sports sectors. Established in 2009, Elixirr International plc maintains its primary corporate office in London, United Kingdom.
Key people
Gavin Patterson
Independent Non-Executive Chairman of the Board · since 2019
Graham Busby
Deputy Chief Executive Officer, Co-Founder, Executive Director · since 2025
Nicholas Willott
Chief Financial Officer, Executive Director, Company Secretary · since 2025
Stephen Newton
Chief Executive Officer, Co-Founder, Executive Director · since 2018
Bill Michael
Non-Executive Director · since 2026
Simon Retter
Independent Non-Executive Director · since 2020
Charlotte Stranner
Independent Non-Executive Director · since 2020
Legal address
12 HELMET ROW
LONDON, LND EC1V 3QJ
GB
LONDON, LND EC1V 3QJ
GB
Headquarters
100 CHEAPSIDE
LONDON, LND EC2V 6DT
GB
LONDON, LND EC2V 6DT
GB
Previous name
ELIXIRR INTERNATIONAL LIMITED
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑04 | 2017‑04 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||